The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

Chances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

Once hailed primarily as a diabetes drug and later catapulted into stardom for its weight-loss benefits, Ozempic (semaglutide ...

semaglutide resolved steatohepatitis in 63% of patients and reduced liver fibrosis, while also promoting weight loss and improving metabolic health in people with advanced fatty liver disease.